PP
TYRA icon

PDT Partners’s Tyra Biosciences TYRA Stock Holding History

PDT Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62M Hold
42,284
– – 0.1% 271
2025
Q4 		$1.11M Sell
42,284
-1,026
-2% -$18.8K 0.07% 338
2025
Q3 		$606K Hold
43,310
– – 0.04% 426
2025
Q2 		$414K Buy
+43,310
New +$412K 0.02% 548
2025
Q1 		– Sell
-20,359
Closed -$283K – 859
2024
Q4 		$283K Buy
+20,359
New +$369K 0.03% 592
2024
Q3 		– Sell
-15,306
Closed -$245K – 826
2024
Q2 		$245K Buy
15,306
+3,132
+26% +$53.9K 0.02% 584
2024
Q1 		$200K Buy
+12,174
New +$200K 0.02% 576

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

PDT Partners's TYRA Position: Q1 2026 in Review

PDT Partners held its Tyra Biosciences (TYRA) position steady in Q1 2026 at 42,284 shares worth $1.62M. The position accounts for 0.1% of the portfolio, ranked #271.

PDT Partners first reported a position in TYRA in Q1 2024 and has held it in 7 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • PDT Partners held 42,284 shares of Tyra Biosciences worth $1.62M as of Q1 2026.
  • PDT Partners left its Tyra Biosciences share count unchanged in Q1 2026.
  • Tyra Biosciences made up 0.1% of PDT Partners's portfolio in Q1 2026, its #271 holding.
  • PDT Partners first reported a position in Tyra Biosciences in Q1 2024 and has held it in 7 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.